INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
Subscribe
INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
SEARCH
SEARCH
advanced search
Connecting Drug Delivery
149
Issue No #149 June 2023
June 17th, 2023
Download PDF
Issue 149 - Jun 2023
Inside the magazine
INTERVIEW
Jim McGough
EdgeOne Medical
CONNECTING PHARMA: INSIGHTS FROM AUTOMOTIVE INDUSTRY EXPERIENCE
Jim McGough talks with Guy Furness about the current state and future of connectivity in drug delivery and pharma more broadly. In an enlightening discussion, Mr McGough shares insights from his time pioneering connectivity in the automotive industry at Volkswagen Group and how those lessons might apply to pharma, as well as considering what might be holding the industry back from going full steam ahead on connectivity and how that might change over the next decade.
CONNECTIVITY
Ali Badiei
Gerresheimer
DIGITAL TWIN IN THE PHARMACEUTICAL SUPPLY CHAIN
Gerresheimer’s Ali Badiei explains the role of digital twin technology and its integration into the pharmaceutical supply chain, highlighting an innovative approach to ensuring drug identity and quality.
CONNECTIVITY
Dr Kate Hudson-Farmer
PA Consulting
REIMAGINING AUTOINJECTOR CONNECTIVITY
Kate Hudson-Farmer and Simon Hall discuss a new smartphone-based connectivity solution for autoinjectors that requires no additional hardware and works with most autoinjectors and smartphones.
CONNECTIVITY
Ventsislav Dobrev
Ypsomed
Real-World Evidence in the Age of Digital Health – Unlocking Value for Pharmaceutical Companies
Ventsislav Dobrev, Philippe Müller and Rafael Weiler explore how real-world evidence in the age of digital health can help unlock value for pharmaceutical companies.
CONNECTIVITY
Dr Corinne Fechant
Aptar Pharma
TAKING A PATIENT-CENTRIC APPROACH TO CANCER CARE THROUGH IMMUNOTHERAPY
Corinne Fechant and Laura Hilliquin highlight the role digital health solutions can play in supporting patient self-administration for the increasing number of immunotherapies for cancer treatment.
CONNECTIVITY
Fallyn Flaherty-Earp
Celanese
LESSONS FROM MARKETED MEDICAL DEVICES TO ENHANCE CONNECTED DRUG DELIVERY
Fallyn Flaherty-Earp looks at what medical device manufacturers can learn from connected devices already on the market and discusses the opportunities electronic inks can provide for the development of innovative therapies for the treatment of chronic diseases.
CONNECTIVITY
Sylvia Kaiser
NXP Semiconductors
EMPOWERING PATIENTS FOR SELF-CARE WITH NFC CONNECTIVITY
Sylvia Kaiser-Kershaw looks at how near-field communication technology can be used to add connectivity to medical devices, empowering patients to self-administer medication.
INTERVIEW
Arnaud Guillet
Biocorp
Interview with Arnaud Guillet & Fanny Sellier
Arnaud Guillet and Fanny Sellier talk with Guy Furness about how Biocorp has become a key player in the field of connected drug delivery, discuss the current landscape for connectivity in drug delivery and update us on its two major parenteral products – Mallya and Injay – as well as looking forward to the launch of the company’s next generation of connected drug delivery solutions.
EXPERT VIEW
Dr Carolina Dantas
THE POTENTIAL OF CONNECTIVITY AND MONITORING IN MESH NEBULISERS
Carolina Dantas and Ulf Krueger review the current connectivity and remote monitoring capabilities in mesh nebulisers – and their potential to impact patients’ healthcare journeys and the clinical development of inhaled therapies.
CONNECTIVITY
Chelsea Williams
SHL Medical
COLLABORATIVE INNOVATION IN CONNECTED AUTOINJECTORS: HIGH-IMPACT ADHERENCE SOLUTIONS
Chelsea Williams, Nils Weber and Gene Rhode Fuensalida Pantig discuss the potential of collaborative innovation in connected drug delivery when it comes to creating high-impact, low-touch adherence solutions.
EXPERT VIEW
Dan Lock
THE IRONIES OF AUTOMATION: LESSONS FOR REMOTE PATIENT MONITORING
Dan Lock considers how to overcome potential pitfalls and make the most of remote patient monitoring for the benefit of both patient care and clinical trials.
Top
